Iron deficiency and short-term adverse events in patients with decompensated heart failure

Background For patients with heart failure (HF), iron deficiency (ID) is a common therapeutic target. However, little is known about the utility of transferrin saturation (TSAT) or serum ferritin for risk stratification in decompensated HF (DHF) or the European Society of Cardiology's (ESC) cur...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical research in cardiology 2021-08, Vol.110 (8), p.1292-1298
Hauptverfasser:	Palau, Patricia, Llàcer, Pau, Domínguez, Eloy, Tormo, Juan Pablo, Zakarne, Rim, Mollar, Anna, Martínez, Ana, Miñana, Gema, Santas, Enrique, Almenar, Luis, Fácila, Lorenzo, De La Espriella, Rafael, Núñez, Eduardo, Manzano, Luis, Bayés-Genís, Antoni, Núñez, Julio
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biomarkers - blood Cardiology Confidence intervals Congestive heart failure Evaluation Female Ferritin Ferritins - blood Heart failure Heart Failure - blood Humans Iron Iron Deficiencies - complications Iron deficiency Male Markers Medicine Medicine & Public Health Natriuretic Peptide, Brain - blood Nutrient deficiency Original Paper Patient Readmission Patients Peptide Fragments - blood Quartiles Registries Retrospective Studies Risk Risk Assessment Risk Factors Statistical analysis Stroke Volume Therapeutic targets Transferrin Transferrins Transferrins - blood Ventricle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background For patients with heart failure (HF), iron deficiency (ID) is a common therapeutic target. However, little is known about the utility of transferrin saturation (TSAT) or serum ferritin for risk stratification in decompensated HF (DHF) or the European Society of Cardiology's (ESC) current definition of ID (ferritin
ISSN:	1861-0684 1861-0692
DOI:	10.1007/s00392-021-01832-z